Pilatus Biosciences inks clinical trial collaboration with Roche to evaluate PLT012 in first-in-human study in hepatocellular carcinoma: Epalinges, Switzerland Saturday, August 16 ...

Vyome Therapeutics receives Nasdaq Stock Market approval to merge with ReShape Lifesciences: Cambridge, Massachusetts Saturday, August 16, 2025, 17:00 Hrs [IST] Vyome Therapeutics ...

Study reveals how small changes in walking technique may help treat knee osteoarthritis: New York Saturday, August 16, 2025, 16:00 Hrs [IST] Gait analysis and pain measures show t ...

AleraCare, PURE Healthcare enter into merger agreement to enhance availability of infusion services: Phoenix Saturday, August 16, 2025, 15:00 Hrs [IST] AleraCare, a leading provid ...

Leads Biolabs completes patient enrollment in pivotal trial of Opamtistomig monotherapy for extrapulmonary neuroendocrine carcinoma: Nanjing, China Saturday, August 16, 2025, 14:0 ...

Basilea Pharma enters licensing pact with Venatorx Pharma to acquire rights to ceftibuten-ledaborbactam etzadroxil, a clinical phase 3-ready oral BL/BLI combo to treat cUTI Allschwil, Switzerland ...